Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
929.65
6.00 (0.65%)
< Home < Back

NATCO Pharma informs about disclosure

Date: 16-11-2022

NATCO Pharma has informed that it enclosed the disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 for the information.

The above information is a part of company’s filings submitted to BSE.